• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Response to "Efficacy of sonidegib in histologic subtypes of advanced basal cell carcinoma: Results from the final analysis of the randomized phase 2 Basal Cell Carcinoma Outcomes with LDE225 Treatment (BOLT) trial at 42 months".

作者信息

Villani Alessia, Fabbrocini Gabriella, Costa Claudia, Scalvenzi Massimiliano

机构信息

Dermatology Unit, Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy.

Dermatology Unit, Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy.

出版信息

J Am Acad Dermatol. 2021 Jun;84(6):e299-e300. doi: 10.1016/j.jaad.2021.02.074. Epub 2021 Mar 4.

DOI:10.1016/j.jaad.2021.02.074
PMID:33677004
Abstract
摘要

相似文献

1
Response to "Efficacy of sonidegib in histologic subtypes of advanced basal cell carcinoma: Results from the final analysis of the randomized phase 2 Basal Cell Carcinoma Outcomes with LDE225 Treatment (BOLT) trial at 42 months".
J Am Acad Dermatol. 2021 Jun;84(6):e299-e300. doi: 10.1016/j.jaad.2021.02.074. Epub 2021 Mar 4.
2
Efficacy of sonidegib in histologic subtypes of advanced basal cell carcinoma: Results from the final analysis of the randomized phase 2 Basal Cell Carcinoma Outcomes With LDE225 Treatment (BOLT) trial at 42 months.索尼德吉治疗晚期基底细胞癌组织学亚型的疗效：LDE225治疗基底细胞癌结局（BOLT）随机2期试验42个月最终分析结果
J Am Acad Dermatol. 2021 Apr;84(4):1162-1164. doi: 10.1016/j.jaad.2020.08.042. Epub 2020 Dec 24.
3
The 12-month analysis from Basal Cell Carcinoma Outcomes with LDE225 Treatment (BOLT): A phase II, randomized, double-blind study of sonidegib in patients with advanced basal cell carcinoma.BOLT 研究：隆地替尼治疗基底细胞癌的 12 个月分析：一项评价晚期基底细胞癌患者接受 sonidegib 治疗的 II 期、随机、双盲研究。
J Am Acad Dermatol. 2016 Jul;75(1):113-125.e5. doi: 10.1016/j.jaad.2016.02.1226. Epub 2016 Apr 7.
4
Long-term efficacy and safety of sonidegib in patients with advanced basal cell carcinoma: 42-month analysis of the phase II randomized, double-blind BOLT study.索立德吉治疗晚期基底细胞癌的长期疗效和安全性：II 期随机、双盲 BOLT 研究的 42 个月分析。
Br J Dermatol. 2020 Jun;182(6):1369-1378. doi: 10.1111/bjd.18552. Epub 2019 Dec 8.
5
Sonidegib for the treatment of advanced basal cell carcinoma: a comprehensive review of sonidegib and the BOLT trial with 12-month update.索尼替尼治疗晚期基底细胞癌：全面综述索尼替尼和 BOLT 试验及其 12 个月更新。
Future Oncol. 2016 Sep;12(18):2095-105. doi: 10.2217/fon-2016-0118. Epub 2016 May 18.
6
Treatment with two different doses of sonidegib in patients with locally advanced or metastatic basal cell carcinoma (BOLT): a multicentre, randomised, double-blind phase 2 trial.两种不同剂量的 sonidegib 治疗局部晚期或转移性基底细胞癌（BOLT）患者：一项多中心、随机、双盲 2 期试验。
Lancet Oncol. 2015 Jun;16(6):716-28. doi: 10.1016/S1470-2045(15)70100-2. Epub 2015 May 14.
7
Treatment of advanced basal cell carcinoma with sonidegib: perspective from the 30-month update of the BOLT trial.索立德吉治疗晚期基底细胞癌：BOLT 试验 30 个月更新的观点。
Future Oncol. 2018 Mar;14(6):515-525. doi: 10.2217/fon-2017-0457. Epub 2017 Nov 9.
8
Assessment of various efficacy outcomes using ERIVANCE-like criteria in patients with locally advanced basal cell carcinoma receiving sonidegib: results from a preplanned sensitivity analysis.采用类似于 ERIVANCE 的标准评估局部晚期基底细胞癌患者接受 sonidegib 治疗的各种疗效结局：一项预先计划的敏感性分析结果。
BMC Cancer. 2021 Nov 19;21(1):1244. doi: 10.1186/s12885-021-08968-1.
9
Rapid and exceptional response to Sonidegib in a patient with multiple locally advanced basal cell carcinomas.患者患有多处局部晚期基底细胞癌，对索尼德吉产生快速且显著的应答。
Anticancer Drugs. 2021 Apr 1;32(4):465-468. doi: 10.1097/CAD.0000000000001054.
10
Concomitant medication use does not appear to alter long-term efficacy of sonidegib for advanced basal cell carcinoma: a post hoc analysis based on the 42-month BOLT study.伴随药物治疗似乎不会改变索立德吉治疗晚期基底细胞癌的长期疗效：基于 42 个月 BOLT 研究的事后分析。
Eur J Dermatol. 2023 Jun 1;33(3):280-286. doi: 10.1684/ejd.2023.4498.

引用本文的文献

1
Basal Cell Carcinoma: An Old Friend with Multiple Faces.基底细胞癌：一位有着多副面孔的老朋友。
Cancers (Basel). 2025 Mar 15;17(6):993. doi: 10.3390/cancers17060993.
2
Basosquamous Carcinoma: Comprehensive Clinical and Histopathological Aspects, Novel Imaging Tools, and Therapeutic Approaches.基底鳞状细胞癌：全面的临床和组织病理学方面、新型影像学工具和治疗方法。
Cells. 2023 Nov 30;12(23):2737. doi: 10.3390/cells12232737.
3
Sonidegib in Locally Advanced Basal Cell Carcinoma: A Monocentric Retrospective Experience and a Review of Published Real-Life Data.
索纳替尼治疗局部晚期基底细胞癌：一项单中心回顾性研究及已发表的真实世界数据综述
Cancers (Basel). 2023 Jul 14;15(14):3621. doi: 10.3390/cancers15143621.